Nd. Ridgway, INHIBITION OF ACYL-COA-CHOLESTEROL ACYLTRANSFERASE IN CHINESE-HAMSTEROVARY (CHO) CELLS BY SHORT-CHAIN CERAMIDE AND DIHYDROCERAMIDE, Biochimica et biophysica acta, L. Lipids and lipid metabolism, 1256(1), 1995, pp. 39-46
The biological activity of ceramide, an intermediate in the synthesis
and catabolism of sphingolipids, has been shown to be mimicked by shor
t-chain N-acyl analogues. A potential role for ceramide in modulating
cholesterol esterification was investigated using a series of short-ch
ain ceramides and dihydroceramides. Acyl-CoA:cholesterol acyltransfera
se (ACAT) in CHO cells was inhibited rapidly (< 30 min) and in a dose-
dependent fashion by two N-acyl analogues of naturally occurring D-ery
thro-ceramide, N-acetyl-sphingosine (D-erythro-C-2-ceramide) and N-hex
anoyl-sphingosine (D-erythro-C-6-ceramide). At 10 mu M D-erythro-C-2-c
eramide, esterification of cholesterol was inhibited by 95% in CHO cel
ls grown in delipidated serum, and 80-85% in cells grown in 25-hydroxy
cholesterol or human low-density lipoprotein (LDL). D-erythro-C-2-Cera
mide did not inhibit [C-14]oleate-labelling of triacylglycerol and pho
spholipid. Inhibition of cholesterol esterification in cells and isola
ted membranes required the D-erythro (2S,3R) configuration (the L-thre
o isomer of C-2-ceramide was not inhibitory) and an N-acyl group (sphi
ngosine and sphinganine did not inhibit). DL-erythro-C-2-Dihydrocerami
de was also a potent ACAT inhibitor in isolated membranes (IC50 0.2 mu
M) and cells indicating lack of requirement for a 4-trans double bond
. Consistent with results for C-2-ceramides, DL-threo-C-2-dihydroceram
ide was not inhibitory in cells or in vitro. Long-chain ceramide and N
-palmitoyl-dihydroceramide did not inhibit ACAT in isolated membranes.
Compared to D-erythro-C-2-ceramide, D-erythro-C-6- and C-4-ceramide w
ere slightly weaker inhibitors of ACAT in isolated membranes. Thus, N-
acyl chain length could influence inhibition, either by altering the e
ffective concentration of ceramide in membranes or affinity for the AC
AT enzyme. Short-chain ceramides and dihydroceramides are the first AC
AT inhibitors described with structural similarity to a naturally occu
rring compound.